Lantus Pediatric (Under 12): School and Activity Considerations

What Is Lantus and Why Does It Matter in Young Children?

Lantus (insulin glargine U-100, Sanofi) is a long-acting basal insulin that provides a steady, peakless insulin background over 20 to 24 hours. In children under 12 with type 1 diabetes, basal insulin coverage is the foundation of glucose management because the pancreas produces no meaningful endogenous insulin. The FDA approved insulin glargine U-100 for pediatric patients 6 years and older in 2000, and it is used in younger children based on clinical judgment and published pediatric data [1].

A 2013 multinational trial published in Diabetes Care (N=349 children aged 2 to 5 years) found that insulin glargine produced comparable glycemic control to NPH insulin with a lower rate of severe nocturnal hypoglycemia (3.7 vs. 5.4 events per patient-year, P<0.05), supporting its off-label use below age 6 [2].

How Basal Insulin Differs From Bolus Insulin in a School Context

Basal insulin like Lantus is injected once daily, usually at bedtime or morning, and is not given at school in most regimens. Bolus (mealtime) insulin, given for carbohydrate intake and corrections, is the insulin most frequently administered during school hours. School staff should understand this distinction: Lantus itself rarely causes acute problems at school, but its background effect interacts with activity, missed meals, and stress to influence mid-day glucose levels [3].

FDA Label and Pediatric Dosing Basics

The prescribing information for Lantus states a starting dose of approximately 0.2 units/kg/day in insulin-naive pediatric patients with type 1 diabetes, titrated to fasting glucose targets [1]. Children transitioning from NPH insulin typically begin Lantus at 80% of the total daily NPH dose. Dose requirements increase during growth spurts and illness and decrease during sustained physical activity periods such as sports seasons [4].

School-Day Glucose Monitoring Requirements

Every child with type 1 diabetes on basal-bolus insulin therapy needs a blood glucose monitoring schedule written into a Diabetes Medical Management Plan (DMMP). The ADA's 2024 Standards of Care recommend that children check glucose before meals, before and after physical education, and when symptoms of hypoglycemia arise [3].

Continuous Glucose Monitors at School

Continuous glucose monitors (CGMs) such as the Dexcom G7 or Abbott FreeStyle Libre 3 are now considered standard of care for pediatric type 1 diabetes. The DIAMOND trial demonstrated that CGM use in patients on multiple daily injections (including basal-bolus regimens) reduced HbA1c by 1.0% (P<0.001) compared to self-monitored blood glucose [5]. Schools must allow CGM receivers, smartphones used as CGM displays, or smartwatches to remain with the child or be accessible within one minute [3].

A school nurse or trained staff member should know how to interpret CGM alarms. A "LOW" alarm set at 80 mg/dL gives roughly 10 to 20 minutes of lead time before the child reaches the hypoglycemia threshold of 70 mg/dL.

Blood Glucose Targets During School Hours

The ADA 2024 pediatric targets for children under 12 are [3]:

| Time of Day | Target Range | |---|---| | Before meals | 90 to 130 mg/dL | | 2 hours post-meal | <180 mg/dL | | Bedtime | 90 to 150 mg/dL | | Before physical activity | 126 to 180 mg/dL |

Values below 70 mg/dL require immediate treatment. Values below 54 mg/dL are classified as clinically significant hypoglycemia requiring glucagon [3].

Physical Activity: The Biggest Variable in Pediatric Basal Insulin Management

Exercise is the single most unpredictable factor in pediatric insulin management during school. Aerobic activity increases glucose uptake in muscle independent of insulin, meaning the fixed background of Lantus creates proportionally more glucose-lowering effect when a child runs, swims, or plays basketball [6].

How Exercise Type Affects Blood Glucose

Research published in Diabetes Care (DirecNet Study Group, N=50 children aged 8 to 17) showed that 75 minutes of moderate aerobic exercise caused mean blood glucose to fall from 193 mg/dL to 144 mg/dL, a drop of 49 mg/dL, while 75 minutes of resistance exercise produced only a 12 mg/dL decline [6]. High-intensity anaerobic bursts (sprinting, wrestling) can transiently raise glucose through catecholamine release before a delayed drop occurs 2 to 3 hours later.

School physical education classes typically combine aerobic and anaerobic elements. The practical implication: check glucose before PE, provide 15 to 20 grams of rapid-acting carbohydrate if the pre-PE reading is below 126 mg/dL, and recheck 30 to 45 minutes after class ends [4].

Basal Insulin Dose Adjustments for Active Children

Unlike pump therapy, Lantus cannot be temporarily suspended. For children with predictably high activity levels (e.g., a 10-year-old who has soccer practice three afternoons per week), the physician may reduce the Lantus dose by 10 to 20% on practice days or shift the injection timing [4]. A prospective study in Pediatric Diabetes (N=112, ages 6 to 14) found that a 20% reduction in basal insulin dose on planned exercise days reduced exercise-induced hypoglycemia events from 18.4% to 7.1% of exercise sessions (P<0.01) [7].

Parents should communicate active-season schedule changes to the prescribing physician so dose adjustments are formalized in the DMMP rather than improvised at school.

After-School Sports and Delayed Hypoglycemia

Lantus has no pronounced peak, but the glucose-lowering effect of exercise can persist for 6 to 12 hours post-activity. A child who plays soccer from 3:00 to 5:00 PM may experience hypoglycemia at 9:00 to 11:00 PM when the Lantus dose coincides with this delayed effect [6]. Setting a bedtime glucose target of 120 to 150 mg/dL (rather than the standard 90 to 150 mg/dL) on heavy exercise days is a common clinical strategy supported by ADA guidance [3].

Writing an Effective Diabetes Medical Management Plan

The DMMP is the legal and clinical document that governs diabetes care at school. Federal law under Section 504 of the Rehabilitation Act requires public schools to accommodate students with diabetes at no cost to the family. The American Diabetes Association's Safe at School initiative provides a model DMMP template updated annually [8].

Core Elements Every DMMP Must Include

A complete DMMP for a child on Lantus should specify [8]:

• The child's current Lantus dose, injection site rotation, and injection time
• Which staff member is trained and authorized to administer glucagon
• The BG threshold that triggers a hypoglycemia snack (typically 80 to 100 mg/dL)
• The BG threshold that triggers glucagon administration (typically below 54 mg/dL or loss of consciousness)
• Carbohydrate-to-insulin ratios for bolus insulin given at lunch
• Pre-PE glucose check requirement and carbohydrate supplement protocol
• Permission for the child to carry glucose tablets or gel
• CGM alarm settings and who receives remote alerts

Who Signs the DMMP

The DMMP must be signed by the prescribing physician or nurse practitioner, the parent or guardian, and the school principal. It should be updated at the start of each academic year and after any significant change in insulin regimen, such as a Lantus dose adjustment of 20% or more [8].

Communicating With School Staff

Research from the T1D Exchange Quality Improvement Collaborative (N=3,102 pediatric patients) found that only 54% of school-aged children with type 1 diabetes had a current DMMP on file at their school, and that the absence of a DMMP correlated with a higher rate of severe hypoglycemia events at school [9]. Structured communication between the diabetes care team and school nurse at the start of each year reduces this gap.

Hypoglycemia Recognition and Treatment at School

Hypoglycemia is the most common acute complication of Lantus-based regimens in children. Children under 12 often cannot reliably self-report early symptoms like diaphoresis or tremor; instead, teachers may notice behavioral changes such as irritability, difficulty concentrating, or sudden fatigue [3].

The Rule of 15

The ADA recommends the "Rule of 15" for mild to moderate hypoglycemia (BG 54 to 70 mg/dL): give 15 grams of fast-acting carbohydrate, wait 15 minutes, recheck glucose. Repeat if still below 70 mg/dL. Every classroom and the school nurse office should stock glucose tablets, juice boxes (approximately 15 grams per 4-ounce box), or glucose gel [3].

Severe Hypoglycemia and Glucagon

Severe hypoglycemia (BG <54 mg/dL or loss of consciousness or seizure) requires glucagon. Nasal glucagon (Baqsimi, 3 mg intranasal) and ready-to-inject glucagon (GlucaGen, Gvoke) eliminate the need for mixing, making them practical for school settings [10]. A 2019 phase 3 trial published in NEJM (N=68 children aged 4 to 17) showed nasal glucagon achieved treatment success (BG recovery to above 70 mg/dL or symptom resolution within 30 minutes) in 100% of treated subjects, equivalent to intramuscular glucagon [10].

At least one staff member at school should be trained annually in glucagon administration. The DMMP should name this person and an identified backup.

When to Call 911

Call emergency services immediately if the child does not respond to glucagon within 15 minutes, if seizure activity lasts more than 5 minutes, or if staff cannot safely administer treatment. Do not delay emergency services to contact parents first [8].

Storing Lantus at School

Insulin glargine is stable at room temperature (below 77°F or 25°C) for up to 28 days once a vial or pen is in use. The FDA-approved prescribing label states unopened Lantus vials must be refrigerated between 36 and 46°F and should not be frozen [1]. Schools should designate a secure, climate-controlled location, typically the nurse's office, for insulin storage. The child's backup vial or pen should be kept there, not in a locker or backpack where temperature fluctuates.

In regions with hot weather, a FRIO cooling pouch maintains safe temperatures for insulin without refrigeration for up to 45 hours, making it practical for field trips and outdoor events [4].

Field Trips, Overnight Events, and Special Circumstances

Field trips require advance planning beyond the standard DMMP. The school must arrange for a trained adult to accompany the child at all times with the full diabetes kit: glucose meter or CGM, insulin pen with Lantus and bolus insulin, carbohydrate sources, and glucagon [8].

Overnight School Events

Children on Lantus attending overnight school trips need their bedtime Lantus dose administered by a trained adult, not skipped. A missed basal dose causes ketone production within 4 to 8 hours in type 1 diabetes [4]. The ADA recommends parents provide written instructions for overnight events and, where possible, arrange for the child's personal diabetes educator to provide a training session for chaperones in advance [3].

Illness at School

Intercurrent illness raises counterregulatory hormones and typically increases insulin requirements. The "sick day rule" for basal insulin is to never omit Lantus even if the child is vomiting, because basal insulin is needed to prevent diabetic ketoacidosis. Parents should have a sick-day action plan on file with the school nurse specifying ketone check thresholds and when to call the physician [4].

A cohort study in Pediatric Diabetes (N=187, ages 3 to 12) found that 41% of DKA episodes in school-aged children began during an intercurrent illness that was not recognized as requiring immediate insulin adjustment [11].

Communicating With the Diabetes Care Team Throughout the School Year

Lantus dose requirements in children under 12 change frequently. Growth-related insulin resistance, puberty onset (even in late elementary school children), illness, and seasonal activity changes all shift the optimal basal dose. The ADA recommends clinic visits every 3 months for children with type 1 diabetes [3].

Parents should share school-generated glucose data, including any hypoglycemia records, with the endocrinologist or diabetes care team at each visit. Most CGM platforms allow remote data sharing via Dexcom Clarity or LibreView, so the care team can review school-hour glucose patterns without waiting for the next appointment. A retrospective analysis in Diabetes Technology and Therapeutics (N=421 pediatric patients) found that remote CGM data review between visits was associated with a 0.4% lower HbA1c at the following clinic visit compared to no between-visit data sharing (P<0.001) [12].

The ADA 2024 Standards of Care state directly: "Children and adolescents with diabetes should have access to a diabetes care team with pediatric expertise, and school-based diabetes management plans should be reviewed and updated at least annually or whenever the treatment regimen changes" [3].

ADA and Endocrine Society Guidance on Pediatric Basal Insulin Selection

Both the ADA and the Pediatric Endocrine Society recommend basal insulin analogs (glargine or detemir) over NPH insulin in children because of their lower hypoglycemia risk and more predictable pharmacokinetics [3, 13]. The Endocrine Society's 2022 clinical practice guideline on type 1 diabetes management states: "Insulin analogs are preferred over human insulin preparations in children and adolescents with type 1 diabetes to reduce hypoglycemia risk" [13].

A Cochrane systematic review (14 trials, N=1,279 pediatric patients) comparing insulin analogs to NPH in children found that glargine reduced severe hypoglycemia episodes by 29% (relative risk 0.71, 95% CI 0.57 to 0.89) with no significant difference in HbA1c [14].

Practical Checklist for the Start of Each School Year

Parents and care teams should complete the following before the first day of school [3, 8]:

1. Schedule a meeting with the school nurse to review the updated DMMP.
2. Confirm that at least two staff members are trained in glucagon administration.
3. Provide the school with a full diabetes supply kit: meter, CGM supplies, insulin pen, needles, glucose tablets, glucagon, and a sharps container.
4. Set CGM sharing permissions so the school nurse receives remote alarms.
5. Verify that the child's backup Lantus vial or pen is stored in the nurse's office and is not expired.
6. Update the PE teacher on pre-activity glucose targets and snack protocol.
7. Confirm the child's 504 Plan or IEP includes specific diabetes accommodations such as unrestricted bathroom access, permission to eat in class, and extended test time after hypoglycemia episodes.

The ADA Safe at School program provides free downloadable model 504 plans and DMMP templates at diabetes.org, updated to reflect the 2024 Standards of Care [8].

Children using Lantus once daily at home may have their lowest glucose values during the school day if the injection is given in the morning. For a child injecting Lantus at 7:00 AM, the maximum effect window of 10 to 16 hours post-injection falls between 5:00 PM and 11:00 PM, but school-hour glucose can still be influenced by the steady background. The prescribing physician should clarify whether a morning or bedtime injection best fits the child's school schedule and monitoring capacity.

Target HbA1c for children under 12 per ADA 2024 Standards of Care is below 7.5%, recognizing that overly aggressive targets increase hypoglycemia risk in this age group, where hypoglycemia unawareness is more common and more dangerous [3].